FDA puts BioNTech’s malaria vaccine on clinical hold

BioNTech has paused an early-stage study of its experimental malaria vaccine after the FDA handed it a clinical hold, the biotech disclosed Tuesday in a securities filing. The company did not provide a reason for ...